Clinical Trials Browser

Withdrawn × Smoldering Multiple Myeloma × Clear all

NCT02298816 2024-10-03

HMvax-Regist

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Influenza, Human, Lymphocytosis, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Pneumonia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Hematologic Neoplasms

NCT03591614 2023-08-18

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Phase EARLY_PHASE1 Withdrawn

Smoldering Multiple Myeloma, Paraproteinemias, Neoplasms, Plasma Cell

NCT01571726 2019-12-16

Imaging Studies and the Development of Multiple Myeloma

Phase 2 Withdrawn

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT03952832 2019-11-14

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Phase 2 Withdrawn

Smoldering Multiple Myeloma

NCT00503763 2015-04-16

PSMMSS

Phase 2 Withdrawn

Smoldering Multiple Myeloma